This company has been marked as potentially delisted and may not be actively trading. Leisure Acquisition (LACQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock LACQ vs. EGRX, AADI, OSTX, ATNM, NBRV, ELYM, MRNS, HILS, ALLK, and CARAShould you be buying Leisure Acquisition stock or one of its competitors? The main competitors of Leisure Acquisition include Eagle Pharmaceuticals (EGRX), Aadi Bioscience (AADI), OS Therapies (OSTX), Actinium Pharmaceuticals (ATNM), Nabriva Therapeutics (NBRV), Eliem Therapeutics (ELYM), Marinus Pharmaceuticals (MRNS), Hillstream BioPharma (HILS), Allakos (ALLK), and Cara Therapeutics (CARA). Leisure Acquisition vs. Its Competitors Eagle Pharmaceuticals Aadi Bioscience OS Therapies Actinium Pharmaceuticals Nabriva Therapeutics Eliem Therapeutics Marinus Pharmaceuticals Hillstream BioPharma Allakos Cara Therapeutics Leisure Acquisition (NASDAQ:LACQ) and Eagle Pharmaceuticals (NASDAQ:EGRX) are both small-cap pharmaceutical preparations industry companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations. Which has preferable earnings and valuation, LACQ or EGRX? Eagle Pharmaceuticals has higher revenue and earnings than Leisure Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLeisure AcquisitionN/AN/A$4.31MN/AN/AEagle Pharmaceuticals$257.55M0.18$35.64MN/AN/A Is LACQ or EGRX more profitable? Leisure Acquisition's return on equity of 30.17% beat Eagle Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Leisure AcquisitionN/A 30.17% 6.14% Eagle Pharmaceuticals N/A N/A N/A Do institutionals & insiders hold more shares of LACQ or EGRX? 56.7% of Leisure Acquisition shares are owned by institutional investors. Comparatively, 85.4% of Eagle Pharmaceuticals shares are owned by institutional investors. 39.6% of Leisure Acquisition shares are owned by company insiders. Comparatively, 28.9% of Eagle Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more risk and volatility, LACQ or EGRX? Leisure Acquisition has a beta of -0.3, indicating that its stock price is 130% less volatile than the S&P 500. Comparatively, Eagle Pharmaceuticals has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Does the media refer more to LACQ or EGRX? In the previous week, Eagle Pharmaceuticals had 1 more articles in the media than Leisure Acquisition. MarketBeat recorded 1 mentions for Eagle Pharmaceuticals and 0 mentions for Leisure Acquisition. Eagle Pharmaceuticals' average media sentiment score of 0.00 beat Leisure Acquisition's score of -1.38 indicating that Eagle Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Leisure Acquisition Negative Eagle Pharmaceuticals Neutral SummaryEagle Pharmaceuticals beats Leisure Acquisition on 6 of the 9 factors compared between the two stocks. Get Leisure Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for LACQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LACQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LACQ vs. The Competition Export to ExcelMetricLeisure AcquisitionPharmaceutical Preparations Industry SectorNASDAQ ExchangeMarket Cap$13.44M$872.67M$2.01B$9.09BDividend YieldN/A4.84%13.72%4.00%P/E RatioN/A1.3812.2820.27Price / SalesN/A239.362,543,431.7798.57Price / Cash20.0317.6961.9458.16Price / Book-11.376.583.225.49Net Income$4.31M-$23.83M-$475.68M$250.45M Leisure Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LACQLeisure AcquisitionN/A$2.16+3.3%N/A+345.5%$13.44MN/A0.00N/ANegative NewsHigh Trading VolumeEGRXEagle Pharmaceuticals2.4585 of 5 stars$3.87+19.1%N/A-41.1%$50.26M$257.55M0.00100News CoverageGap DownAADIAadi Bioscience0.4713 of 5 stars$1.99+0.5%$1.67-16.2%+31.3%$49.15M$25.07M-0.8740OSTXOS Therapies1.723 of 5 stars$1.69+4.3%$18.00+965.1%N/A$47.49MN/A-1.97N/ANews CoverageATNMActinium Pharmaceuticals2.8302 of 5 stars$1.52+5.9%$4.00+164.0%N/A$47.26MN/A-1.0930News CoverageNBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070ELYMEliem TherapeuticsN/A$1.28+1.6%N/A-80.9%$38.08MN/A-2.429MRNSMarinus Pharmaceuticals2.2262 of 5 stars$0.55-0.2%$3.92+613.3%-58.7%$30.32M$30.99M-0.22110HILSHillstream BioPharmaN/A$1.69-9.1%N/A-51.6%$29.75MN/A-2.351ALLKAllakos2.9503 of 5 stars$0.33flat$2.00+507.7%N/A$29.74MN/A-0.16190CARACara Therapeutics0.3021 of 5 starsN/AN/AN/A$24.33M$7.14M-0.2580Gap DownHigh Trading Volume Related Companies and Tools Related Companies EGRX Alternatives AADI Alternatives OSTX Alternatives ATNM Alternatives NBRV Alternatives ELYM Alternatives MRNS Alternatives HILS Alternatives ALLK Alternatives CARA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LACQ) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Leisure Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Leisure Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LACQ Stock Alerts